Symbols

ICUI

ICU Medical·NASDAQ

--(--)

Market Open: --

--(--)

Pre-Market: --

Signals Analysis

Bullish signal 3

Bearish signal 2

Consensus Rating "Buy"

MACD Death Cross

Ample Liquidity

Revenue Beats Expectation

EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About ICUI

Icu Medical, Inc.

A US-based medical device company that develops and manufactures infusion therapy and critical care products

Industry

Healthcare Equipment and Supplies

Established Date

Listing Date

03/31/1992

Exchange

NASDAQ Stock Exchange

Full-time Employees

15,000

Fiscal Year Ends

12-31

Website

www.icumed.com

Security Type

Common stock

Office address

951 Calle Amanecer , San Clemente , California 92673

Business

Introduction

ICU Medical, Inc., was incorporated by its CEO in 1984 and made its initial public offering in 1992. The company is a leader in the development, production and sales of new medical devices for injection therapy, oncology and emergency care. The company's products improve patient recovery by helping to organize blood pressure infections, protecting healthcare workers and patients from exposure to infectious diseases or harmful drugs, and monitoring continuous cardiac output of emergency care patients. The company's complete product line includes custom injection systems, closed delivery systems for hazardous drugs, needle-free injection connectors, catheters and cardiac detection systems.

Earnings Call

Q1/2025

Estimate EPS1.28

Actual EPS1.72

Estimate Revenue574.15M

Actual Revenue604.70M

ICU Medical's Q1 2025: Unpacking Contradictions in Plasma Collection, Tariff Exposure, and Infusion Systems Growth

May 19,2025 11:58·
Earnings Decrypt

Company Financials

EPS

ICUI has released its 2025 Q3 earnings. EPS was reported at 2.03, versus the expected 1.43, beating expectations. The chart below visualizes how ICUI has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

ICUI has released its 2025 Q3 earnings report, with revenue of 536.99M, reflecting a YoY change of -8.85%, and net profit of -3.40M, showing a YoY change of 89.70%. The Sankey diagram below clearly presents ICUI's revenue sources and cost distribution.